Atlas Trials

3-Tesla MRI Response to TACE in HCC (Liver Cancer)

Clinical trial NCT02057874 · TERMINATED

Trial details

NCT number
NCT02057874
Sponsor
Vanderbilt-Ingram Cancer Center
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Resectable Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver CancerStage A Adult Primary Liver Cancer (BCLC)Stage B Adult Primary Liver Cancer (BCLC)
Start date
2014-02-01
Primary completion
2015-11-19
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.